http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101577274-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101577274-B1 |
| titleOfInvention | Nucleotide having endosomolysis activity and uses thereof |
| abstract | The present invention relates to a non-viral drug delivery system comprising a nucleotide and a non-viral drug delivery system, said composition having proton buffering activity or hemolysis activity, wherein the endosomolysis ) To induce endosomal escape of the delivered drug. The non-viral drug delivery compositions of the present invention are for effective drug delivery vehicles capable of escaping drugs delivered by hydrogen ion buffering activity or hemolytic activity of nucleotides from endosomes to other organelles in the cell. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180108190-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190056606-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180118976-A |
| priorityDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.